BioToday.com [新着ニュース] BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。 http://www.biotoday.com/news.cfm biotoday@biotoday.com Copyright © 2012 BioToday Ltd. All Rights Reserved. Tue, 07 Feb 2012 11:14:57 +0900 ja http://blogs.law.harvard.edu/tech/rss http://www.biotoday.com/http://www.biotoday.com/images/title_small.gifBioToday.com [新着ニュース] [企業] Eli Lilly社　大部分の社員の今年の昇給はなし http://feedproxy.google.com/~r/biotoday/~3/AY2Ggu2stVQ/view.cfm http://www.biotoday.com/view.cfm?n=49516&ref=rss ビジネス / 会社運営 / 業績発表・予想 biotoday@biotoday.com Tue, 07 Feb 2012 11:14:57 +0900 http://www.biotoday.com/post_comment.cfm?init=A49516&ref=rss http://www.biotoday.com/view.cfm?n=49516&ref=rss [企業] Anacor社とGSK社　抗生物質GSK2251052全試験患者組み入れを停止 http://feedproxy.google.com/~r/biotoday/~3/N1Fk432AjBg/view.cfm http://www.biotoday.com/view.cfm?n=49515&ref=rss 開発 / 臨床試験 / 第1相試験 || 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Tue, 07 Feb 2012 10:59:50 +0900 http://www.biotoday.com/post_comment.cfm?init=A49515&ref=rss http://www.biotoday.com/view.cfm?n=49515&ref=rss [企業] 前立腺癌骨転移抑制薬としてのXGEVAの価値をFDAは疑問視している http://feedproxy.google.com/~r/biotoday/~3/1WYLttP2-OA/view.cfm http://www.biotoday.com/view.cfm?n=49514&ref=rss 開発 / 承認申請 / 承認申請 biotoday@biotoday.com Tue, 07 Feb 2012 10:33:38 +0900 http://www.biotoday.com/post_comment.cfm?init=A49514&ref=rss http://www.biotoday.com/view.cfm?n=49514&ref=rss [企業] Merck社　不眠薬suvorexantを今年中にFDA承認申請する http://feedproxy.google.com/~r/biotoday/~3/nU6daKMR-Io/view.cfm http://www.biotoday.com/view.cfm?n=49513&ref=rss 開発 / 臨床試験 / 第3相試験 biotoday@biotoday.com Tue, 07 Feb 2012 10:10:56 +0900 http://www.biotoday.com/post_comment.cfm?init=A49513&ref=rss http://www.biotoday.com/view.cfm?n=49513&ref=rss [企業] Teva社の買収標的となりうる2社の最近の動向 http://feedproxy.google.com/~r/biotoday/~3/DDTqWILWcxA/view.cfm http://www.biotoday.com/view.cfm?n=49512&ref=rss ビジネス / 対外交渉 / 合併/買収 biotoday@biotoday.com Tue, 07 Feb 2012 10:02:08 +0900 http://www.biotoday.com/post_comment.cfm?init=A49512&ref=rss http://www.biotoday.com/view.cfm?n=49512&ref=rss [企業] Sanofiの2つの多発性硬化症薬の前途は厳しそうだ http://feedproxy.google.com/~r/biotoday/~3/tT11GpklAtA/view.cfm http://www.biotoday.com/view.cfm?n=49511&ref=rss biotoday@biotoday.com Tue, 07 Feb 2012 09:44:47 +0900 http://www.biotoday.com/post_comment.cfm?init=A49511&ref=rss http://www.biotoday.com/view.cfm?n=49511&ref=rss [企業] 超高感度バイオ分析のXceleron社が英国分析人員を米国拠点に移す http://feedproxy.google.com/~r/biotoday/~3/eok1giiTv0I/view.cfm http://www.biotoday.com/view.cfm?n=49510&ref=rss ビジネス / 会社運営 / 組織変更・事業売却/閉鎖 biotoday@biotoday.com Tue, 07 Feb 2012 07:52:08 +0900 http://www.biotoday.com/post_comment.cfm?init=A49510&ref=rss http://www.biotoday.com/view.cfm?n=49510&ref=rss [企業] Chimerix社　造血幹細胞移植患者CMV疾患予防薬の第2相試験成功 http://feedproxy.google.com/~r/biotoday/~3/O33MrUfA9Fk/view.cfm http://www.biotoday.com/view.cfm?n=49509&ref=rss 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Tue, 07 Feb 2012 07:21:38 +0900 http://www.biotoday.com/post_comment.cfm?init=A49509&ref=rss http://www.biotoday.com/view.cfm?n=49509&ref=rss [企業] United社のRemodulin後発品をSandozがFDAに承認申請した http://feedproxy.google.com/~r/biotoday/~3/DDCaG0fS5QE/view.cfm http://www.biotoday.com/view.cfm?n=49508&ref=rss ビジネス / ジェネリック / 全般 biotoday@biotoday.com Tue, 07 Feb 2012 07:01:12 +0900 http://www.biotoday.com/post_comment.cfm?init=A49508&ref=rss http://www.biotoday.com/view.cfm?n=49508&ref=rss [企業] Swedish Orphan BiovitrumとBiogen Idec　血友病提携の詳細を発表 http://feedproxy.google.com/~r/biotoday/~3/fVgFYzDyzaI/view.cfm http://www.biotoday.com/view.cfm?n=49507&ref=rss ビジネス / 対外交渉 / 企業間提携 biotoday@biotoday.com Tue, 07 Feb 2012 06:50:25 +0900 http://www.biotoday.com/post_comment.cfm?init=A49507&ref=rss http://www.biotoday.com/view.cfm?n=49507&ref=rss [企業] Clinuvel社　骨髄性プロトポルフィリン症薬を欧州承認申請した http://feedproxy.google.com/~r/biotoday/~3/oUM0wWvkZkk/view.cfm http://www.biotoday.com/view.cfm?n=49506&ref=rss 開発 / 承認申請 / 承認申請 biotoday@biotoday.com Tue, 07 Feb 2012 06:37:45 +0900 http://www.biotoday.com/post_comment.cfm?init=A49506&ref=rss http://www.biotoday.com/view.cfm?n=49506&ref=rss [医学] これまでの予想の2倍もの約120万人が2010年にマラリアで死亡した http://feedproxy.google.com/~r/biotoday/~3/BSdxhE9F-gU/view.cfm http://www.biotoday.com/view.cfm?n=49505&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Mon, 06 Feb 2012 19:07:52 +0900 http://www.biotoday.com/post_comment.cfm?init=A49505&ref=rss http://www.biotoday.com/view.cfm?n=49505&ref=rss [医学] 緑茶をよく飲む高齢者は介護が必要となるリスクが低いようだ http://feedproxy.google.com/~r/biotoday/~3/-ZqrHHVJVXM/view.cfm http://www.biotoday.com/view.cfm?n=49504&ref=rss biotoday@biotoday.com Mon, 06 Feb 2012 16:18:09 +0900 http://www.biotoday.com/post_comment.cfm?init=A49504&ref=rss http://www.biotoday.com/view.cfm?n=49504&ref=rss [医学] 母乳保育を受けた子は肺機能がより良好で、喘息になりにくい http://feedproxy.google.com/~r/biotoday/~3/QJ8UVqYZzD8/view.cfm http://www.biotoday.com/view.cfm?n=49503&ref=rss biotoday@biotoday.com Mon, 06 Feb 2012 16:02:02 +0900 http://www.biotoday.com/post_comment.cfm?init=A49503&ref=rss http://www.biotoday.com/view.cfm?n=49503&ref=rss [医学] 人工呼吸必要な急性肺損傷患者の経腸栄養カロリー制限の効果示せず http://feedproxy.google.com/~r/biotoday/~3/quQr4Ebgckk/view.cfm http://www.biotoday.com/view.cfm?n=49502&ref=rss ジャーナル / 総合医学誌 / JAMA biotoday@biotoday.com Mon, 06 Feb 2012 08:57:48 +0900 http://www.biotoday.com/post_comment.cfm?init=A49502&ref=rss http://www.biotoday.com/view.cfm?n=49502&ref=rss [医学] メガベース規模ゲノム変化が60歳以上の人からのみ検出された http://feedproxy.google.com/~r/biotoday/~3/tWzuuG_dGM4/view.cfm http://www.biotoday.com/view.cfm?n=49501&ref=rss biotoday@biotoday.com Mon, 06 Feb 2012 07:56:57 +0900 http://www.biotoday.com/post_comment.cfm?init=A49501&ref=rss http://www.biotoday.com/view.cfm?n=49501&ref=rss [医学] Ca2+調節とPEG利用による損傷神経修復でラットの歩行が劇的に改善 http://feedproxy.google.com/~r/biotoday/~3/fGuxzltRgLc/view.cfm http://www.biotoday.com/view.cfm?n=49500&ref=rss biotoday@biotoday.com Sun, 05 Feb 2012 22:41:54 +0900 http://www.biotoday.com/post_comment.cfm?init=A49500&ref=rss http://www.biotoday.com/view.cfm?n=49500&ref=rss [医学] PCI中のエノキサパリン使用は未分画ヘパリンに勝る/メタ解析 http://feedproxy.google.com/~r/biotoday/~3/YA-h-hn26Gk/view.cfm http://www.biotoday.com/view.cfm?n=49499&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Sat, 04 Feb 2012 18:01:26 +0900 http://www.biotoday.com/post_comment.cfm?init=A49499&ref=rss http://www.biotoday.com/view.cfm?n=49499&ref=rss [医学] 24時間緊急医療で自殺率が最も大きく低下した〜英国での試験 http://feedproxy.google.com/~r/biotoday/~3/NgU7pBu7Hsg/view.cfm http://www.biotoday.com/view.cfm?n=49498&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Sat, 04 Feb 2012 17:38:38 +0900 http://www.biotoday.com/post_comment.cfm?init=A49498&ref=rss http://www.biotoday.com/view.cfm?n=49498&ref=rss [医学] 高血糖は冠動脈硬化のみならず心筋損傷にも寄与しうるようだ http://feedproxy.google.com/~r/biotoday/~3/S5tjLZlmq2c/view.cfm http://www.biotoday.com/view.cfm?n=49497&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 16:59:01 +0900 http://www.biotoday.com/post_comment.cfm?init=A49497&ref=rss http://www.biotoday.com/view.cfm?n=49497&ref=rss [医学] アルツハイマー病の早発型と関連する変異が晩発型とも関連しうる http://feedproxy.google.com/~r/biotoday/~3/hVrLBohjId0/view.cfm http://www.biotoday.com/view.cfm?n=49496&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 16:32:22 +0900 http://www.biotoday.com/post_comment.cfm?init=A49496&ref=rss http://www.biotoday.com/view.cfm?n=49496&ref=rss [医学] カテーテル経由tPA投与で脳出血に伴う血栓を速やかに縮めうる http://feedproxy.google.com/~r/biotoday/~3/zaV5hNXxBbg/view.cfm http://www.biotoday.com/view.cfm?n=49495&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 15:53:25 +0900 http://www.biotoday.com/post_comment.cfm?init=A49495&ref=rss http://www.biotoday.com/view.cfm?n=49495&ref=rss [医学] 睡眠時無呼吸は血管疾患リスク因子の一つとみなすべきかもしれない http://feedproxy.google.com/~r/biotoday/~3/zXQXg9L4zgk/view.cfm http://www.biotoday.com/view.cfm?n=49494&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 15:07:09 +0900 http://www.biotoday.com/post_comment.cfm?init=A49494&ref=rss http://www.biotoday.com/view.cfm?n=49494&ref=rss [医学] レスベラトロールはホスホジエステラーゼ阻害を介して老化を防ぐ http://feedproxy.google.com/~r/biotoday/~3/Ao48Uu7W1Us/view.cfm http://www.biotoday.com/view.cfm?n=49493&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 14:49:57 +0900 http://www.biotoday.com/post_comment.cfm?init=A49493&ref=rss http://www.biotoday.com/view.cfm?n=49493&ref=rss [医学] コーヒーは非アルコール性脂肪肝患者の肝線維症リスクを下げうる http://feedproxy.google.com/~r/biotoday/~3/3kN6tbPwueM/view.cfm http://www.biotoday.com/view.cfm?n=49492&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 14:26:27 +0900 http://www.biotoday.com/post_comment.cfm?init=A49492&ref=rss http://www.biotoday.com/view.cfm?n=49492&ref=rss [企業] Merck KGaA　低酸素標的抗癌剤TH-302権利をThreshold社から取得 http://feedproxy.google.com/~r/biotoday/~3/xR6dDDs0A_0/view.cfm http://www.biotoday.com/view.cfm?n=49491&ref=rss ビジネス / 対外交渉 / 企業間提携 biotoday@biotoday.com Sat, 04 Feb 2012 13:40:04 +0900 http://www.biotoday.com/post_comment.cfm?init=A49491&ref=rss http://www.biotoday.com/view.cfm?n=49491&ref=rss [企業] Merck社　2型糖尿病治療合剤JANUMETがFDAに承認された http://feedproxy.google.com/~r/biotoday/~3/5g2-jGNUARk/view.cfm http://www.biotoday.com/view.cfm?n=49490&ref=rss 開発 / 承認申請 / 承認取得 biotoday@biotoday.com Sat, 04 Feb 2012 13:04:04 +0900 http://www.biotoday.com/post_comment.cfm?init=A49490&ref=rss http://www.biotoday.com/view.cfm?n=49490&ref=rss [企業] Idenix社　C型肝炎薬IDX184の臨床試験差し止めをFDAが解除した http://feedproxy.google.com/~r/biotoday/~3/u3t5J__DREY/view.cfm http://www.biotoday.com/view.cfm?n=49489&ref=rss 開発 / 臨床試験 / 中断 biotoday@biotoday.com Sat, 04 Feb 2012 12:34:49 +0900 http://www.biotoday.com/post_comment.cfm?init=A49489&ref=rss http://www.biotoday.com/view.cfm?n=49489&ref=rss [企業] AstraZeneca社　中国への投資が技術革新を後押しするだろう http://feedproxy.google.com/~r/biotoday/~3/FYr-b_lN-EA/view.cfm http://www.biotoday.com/view.cfm?n=49488&ref=rss ビジネス / 世界の動き / 中国 biotoday@biotoday.com Sat, 04 Feb 2012 12:05:44 +0900 http://www.biotoday.com/post_comment.cfm?init=A49488&ref=rss http://www.biotoday.com/view.cfm?n=49488&ref=rss [企業] 500人を殺した糖尿病薬に関して仏の薬剤規制当局が捜査された http://feedproxy.google.com/~r/biotoday/~3/Qw8kPjTNU3o/view.cfm http://www.biotoday.com/view.cfm?n=49487&ref=rss ビジネス / トラブル / 安全性 biotoday@biotoday.com Sat, 04 Feb 2012 10:59:00 +0900 http://www.biotoday.com/post_comment.cfm?init=A49487&ref=rss http://www.biotoday.com/view.cfm?n=49487&ref=rss [企業] 株主グループがNovartis社役員の再選を阻止しようとしている http://feedproxy.google.com/~r/biotoday/~3/Tkg2gfXS6qo/view.cfm http://www.biotoday.com/view.cfm?n=49486&ref=rss ビジネス / トラブル / その他 biotoday@biotoday.com Sat, 04 Feb 2012 10:36:38 +0900 http://www.biotoday.com/post_comment.cfm?init=A49486&ref=rss http://www.biotoday.com/view.cfm?n=49486&ref=rss [企業] リスペリドンが糖尿病を引き起こすことを示した試験をJ&Jは隠した http://feedproxy.google.com/~r/biotoday/~3/spk15CwpLjw/view.cfm http://www.biotoday.com/view.cfm?n=49485&ref=rss ビジネス / トラブル / 訴訟 biotoday@biotoday.com Sat, 04 Feb 2012 10:19:50 +0900 http://www.biotoday.com/post_comment.cfm?init=A49485&ref=rss http://www.biotoday.com/view.cfm?n=49485&ref=rss [企業] Cardinal Health社　中国での買収に9000万ドルを費やす http://feedproxy.google.com/~r/biotoday/~3/AKJXoDpSwKc/view.cfm http://www.biotoday.com/view.cfm?n=49484&ref=rss ビジネス / 会社運営 / 新規事業・事業拡大 biotoday@biotoday.com Sat, 04 Feb 2012 07:00:15 +0900 http://www.biotoday.com/post_comment.cfm?init=A49484&ref=rss http://www.biotoday.com/view.cfm?n=49484&ref=rss [医学] 知能は社会との関わりを無視して測定できる類のものではない http://feedproxy.google.com/~r/biotoday/~3/5_MOMoAAZ5c/view.cfm http://www.biotoday.com/view.cfm?n=49483&ref=rss biotoday@biotoday.com Sat, 04 Feb 2012 06:44:06 +0900 http://www.biotoday.com/post_comment.cfm?init=A49483&ref=rss http://www.biotoday.com/view.cfm?n=49483&ref=rss [医学] 超高齢者が感じる無力さはうつ病を意味するわけではない http://feedproxy.google.com/~r/biotoday/~3/yg47Dq5kxI0/view.cfm http://www.biotoday.com/view.cfm?n=49482&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 16:37:37 +0900 http://www.biotoday.com/post_comment.cfm?init=A49482&ref=rss http://www.biotoday.com/view.cfm?n=49482&ref=rss [医学] マッサージは高負荷運動後の炎症を鎮め、ミトコンドリア生成を促す http://feedproxy.google.com/~r/biotoday/~3/SrWVVH706Gs/view.cfm http://www.biotoday.com/view.cfm?n=49481&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 16:06:18 +0900 http://www.biotoday.com/post_comment.cfm?init=A49481&ref=rss http://www.biotoday.com/view.cfm?n=49481&ref=rss [医学] 感染症を起こした小児はその後しばらく脳卒中を起こしやすいようだ http://feedproxy.google.com/~r/biotoday/~3/JWFHy2qsAiQ/view.cfm http://www.biotoday.com/view.cfm?n=49480&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 15:38:06 +0900 http://www.biotoday.com/post_comment.cfm?init=A49480&ref=rss http://www.biotoday.com/view.cfm?n=49480&ref=rss [医学] Na+チャンネル活性化の変化が加齢による神経興奮低下に寄与しうる http://feedproxy.google.com/~r/biotoday/~3/BbvgOo8rn94/view.cfm http://www.biotoday.com/view.cfm?n=49479&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 15:14:13 +0900 http://www.biotoday.com/post_comment.cfm?init=A49479&ref=rss http://www.biotoday.com/view.cfm?n=49479&ref=rss [医学] 男性は刺激的/不快な経験、女性は魅力的経験をより正確に記憶する http://feedproxy.google.com/~r/biotoday/~3/fGZilLdxKLo/view.cfm http://www.biotoday.com/view.cfm?n=49478&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 14:45:22 +0900 http://www.biotoday.com/post_comment.cfm?init=A49478&ref=rss http://www.biotoday.com/view.cfm?n=49478&ref=rss [医学] オメガ-3脂肪酸血中レベルが高い高齢者は心房細動を起こしにくい http://feedproxy.google.com/~r/biotoday/~3/ONixFFZFC74/view.cfm http://www.biotoday.com/view.cfm?n=49477&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 13:36:18 +0900 http://www.biotoday.com/post_comment.cfm?init=A49477&ref=rss http://www.biotoday.com/view.cfm?n=49477&ref=rss [医学] 異常タウはシナプスを介して神経間を移動しうる http://feedproxy.google.com/~r/biotoday/~3/HYPry8nuQxQ/view.cfm http://www.biotoday.com/view.cfm?n=49476&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 13:01:46 +0900 http://www.biotoday.com/post_comment.cfm?init=A49476&ref=rss http://www.biotoday.com/view.cfm?n=49476&ref=rss [医学] 多面的教育プログラムの抗生物質使用抑制効果が示された http://feedproxy.google.com/~r/biotoday/~3/4WzUcA5k3n0/view.cfm http://www.biotoday.com/view.cfm?n=49475&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Fri, 03 Feb 2012 12:18:40 +0900 http://www.biotoday.com/post_comment.cfm?init=A49475&ref=rss http://www.biotoday.com/view.cfm?n=49475&ref=rss [医学] V4視覚領域と前頭前皮質の同期が短期視覚記憶保持に必要なようだ http://feedproxy.google.com/~r/biotoday/~3/AvIpze6AMNU/view.cfm http://www.biotoday.com/view.cfm?n=49474&ref=rss biotoday@biotoday.com Fri, 03 Feb 2012 11:19:15 +0900 http://www.biotoday.com/post_comment.cfm?init=A49474&ref=rss http://www.biotoday.com/view.cfm?n=49474&ref=rss [企業] AstraZeneca社　7300人を削減 http://feedproxy.google.com/~r/biotoday/~3/GedV3RkHUXg/view.cfm http://www.biotoday.com/view.cfm?n=49473&ref=rss ビジネス / 会社運営 / 業績発表・予想 || ビジネス / 会社運営 / リストラ biotoday@biotoday.com Fri, 03 Feb 2012 10:33:12 +0900 http://www.biotoday.com/post_comment.cfm?init=A49473&ref=rss http://www.biotoday.com/view.cfm?n=49473&ref=rss [企業] Merrimack社　IPOを延期 http://feedproxy.google.com/~r/biotoday/~3/4m2e6TbNM-A/view.cfm http://www.biotoday.com/view.cfm?n=49472&ref=rss ビジネス / ファイナンス / IPO biotoday@biotoday.com Fri, 03 Feb 2012 10:12:48 +0900 http://www.biotoday.com/post_comment.cfm?init=A49472&ref=rss http://www.biotoday.com/view.cfm?n=49472&ref=rss [企業] GSK社　2000以上のAvandia心臓発作訴訟の和解成立/Bloomberg http://feedproxy.google.com/~r/biotoday/~3/Aud2qcrhTqA/view.cfm http://www.biotoday.com/view.cfm?n=49471&ref=rss ビジネス / トラブル / 訴訟 biotoday@biotoday.com Fri, 03 Feb 2012 09:59:26 +0900 http://www.biotoday.com/post_comment.cfm?init=A49471&ref=rss http://www.biotoday.com/view.cfm?n=49471&ref=rss [企業] Discovery社　人工呼吸患者への吸入医薬品投与技術がFDA承認獲得 http://feedproxy.google.com/~r/biotoday/~3/isWArsGVsOE/view.cfm http://www.biotoday.com/view.cfm?n=49470&ref=rss 開発 / 承認申請 / 承認取得 || 技術 / 医療機器 / 全般 biotoday@biotoday.com Fri, 03 Feb 2012 09:07:51 +0900 http://www.biotoday.com/post_comment.cfm?init=A49470&ref=rss http://www.biotoday.com/view.cfm?n=49470&ref=rss [企業] J&J社の前立腺癌治療薬ZYTIGAの使用をNICEが支持せず http://feedproxy.google.com/~r/biotoday/~3/PMcPaTXAcaU/view.cfm http://www.biotoday.com/view.cfm?n=49469&ref=rss ビジネス / 世界の動き / ヨーロッパ biotoday@biotoday.com Fri, 03 Feb 2012 07:52:29 +0900 http://www.biotoday.com/post_comment.cfm?init=A49469&ref=rss http://www.biotoday.com/view.cfm?n=49469&ref=rss [企業] Sucampo社　lubiprostoneのオピオイド腸機能障害第3相試験が成功 http://feedproxy.google.com/~r/biotoday/~3/DBYjXgj9jD4/view.cfm http://www.biotoday.com/view.cfm?n=49468&ref=rss 開発 / 臨床試験 / 第3相試験 biotoday@biotoday.com Fri, 03 Feb 2012 07:25:11 +0900 http://www.biotoday.com/post_comment.cfm?init=A49468&ref=rss http://www.biotoday.com/view.cfm?n=49468&ref=rss [企業] Agennix社　talactoferrinの重症敗血症第2/3相試験の中止を発表 http://feedproxy.google.com/~r/biotoday/~3/UOwkiHtShQ0/view.cfm http://www.biotoday.com/view.cfm?n=49467&ref=rss 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Fri, 03 Feb 2012 07:08:51 +0900 http://www.biotoday.com/post_comment.cfm?init=A49467&ref=rss http://www.biotoday.com/view.cfm?n=49467&ref=rss